Published in TB and Outbreaks Week, July 19th, 2005
"Resistance to antiretroviral therapy is a determining factor for therapeutic failure in HIV/AIDS. Tire prevalence of primary resistance (i.e. in those patients that have not received treatment) varies in different parts of the world," scientists in Chile report.
"The prevalence of primary resistance to antiretroviral drugs in patients living in Northern Santiago was studied. Viral load, lymphocyte subpopulations by flow cytometry and genotypic resistance testing were assessed in blood samples from 60 HIV-1 infected patients (mean age...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.